Literature DB >> 8392842

Autocrine motility factor is a growth factor.

S Silletti1, A Raz.   

Abstract

Autocrine motility factor (AMF) is a 55 kDa cytokine which is produced and secreted by cancer cells and which regulates cell motility via binding to its receptor, a 78 kDa cell surface glycoprotein (gp78-AMFR), and activating a pertussis toxin (PT)-sensitive G-protein. AMF purified from HT-1080 human fibrosarcoma cells stimulates the growth and motility of 3T3-A31-fibroblasts at a concentration of 0.1 ng/ml or less. The expression of total as well as cell surface gp78-AMFR is down-regulated in contact-inhibited A31-fibroblasts and AMF stimulates the healing of experimentally wounded, density-arrested A31 monolayer cultures. This is the first report of the paracrine and mitogenic actions of AMF and the results presented here show that AMF functions as a growth factor and suggest a possible role for its activity in normal tissue regeneration and tumor cell dissemination.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8392842     DOI: 10.1006/bbrc.1993.1840

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Critical regulation of genes for tumor cell migration by AP-1.

Authors:  El Mustapha Bahassi; Saikumar Karyala; Craig R Tomlinson; Maureen A Sartor; Mario Medvedovic; Robert F Hennigan
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

2.  Tumor autocrine motility factor responses are mediated through cell contact and focal adhesion rearrangement in the absence of new tyrosine phosphorylation in metastatic cells.

Authors:  S Silletti; S Paku; A Raz
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

3.  EGF stimulates lamellipod extension in metastatic mammary adenocarcinoma cells by an actin-dependent mechanism.

Authors:  J E Segall; S Tyerech; L Boselli; S Masseling; J Helft; A Chan; J Jones; J Condeelis
Journal:  Clin Exp Metastasis       Date:  1996-01       Impact factor: 5.150

4.  Dominant negative c-jun inhibits activation of the cyclin D1 and cyclin E kinase complexes.

Authors:  R F Hennigan; P J Stambrook
Journal:  Mol Biol Cell       Date:  2001-08       Impact factor: 4.138

5.  A role for KAI1 in promotion of cell proliferation and mammary gland hyperplasia by the gp78 ubiquitin ligase.

Authors:  Bharat Joshi; Lei Li; Ivan R Nabi
Journal:  J Biol Chem       Date:  2010-01-20       Impact factor: 5.157

Review 6.  12-lipoxygenases and 12(S)-HETE: role in cancer metastasis.

Authors:  K V Honn; D G Tang; X Gao; I A Butovich; B Liu; J Timar; W Hagmann
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

7.  Tumor cell motility and metastasis : Autocrine motility factor as an example of ecto/exoenzyme cytokines.

Authors:  S Silletti; S Paku; A Raz
Journal:  Pathol Oncol Res       Date:  1997-09       Impact factor: 3.201

8.  Localization of autocrine motility factor receptor to caveolae and clathrin-independent internalization of its ligand to smooth endoplasmic reticulum.

Authors:  N Benlimame; P U Le; I R Nabi
Journal:  Mol Biol Cell       Date:  1998-07       Impact factor: 4.138

9.  Characterization of human melanoma cell lines according to their migratory properties in vitro.

Authors:  Luis G Quiñones; Ivette Garcia-Castro
Journal:  In Vitro Cell Dev Biol Anim       Date:  2004 Jan-Feb       Impact factor: 2.416

10.  Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer.

Authors:  Y Hirono; S Fushida; Y Yonemura; H Yamamoto; H Watanabe; A Raz
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.